QuidelOrtho Q3 2022: revenue $783.8M (-21.8% combined const. currency); GAAP EPS $0.28; adjusts guidance up

QuidelOrtho Corp

2022-Q3 EPS reported $9.56 revenue$2,399,500,000

Revenue $783.8M, +54% reported; supplemental combined revenue -21.8% constant currency; ex-COVID +3.0% (underlying +6.0%).
GAAP diluted EPS $0.28 vs $5.08 prior year; adjusted diluted EPS $1.85 vs $4.01 (down 54%).
GAAP operating margin 7% vs 55%; adjusted EBITDA margin 28.9% vs 42.5%.
Full-year 2022 guidance raised; QuidelOrtho integration ahead of expectations.
Base business growth driven by Point-of-Care and Donor Screening; strength in NA, LATAM, ASPAC offset by China/EMEA weakness.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

QuidelOrtho Corp reported third quarter ended October 2, 2022 results: revenue $783.8 million, EPS $0.28. Guidance raised.

Period: third quarter ended October 2, 2022
Revenue: $783.8 million
EPS: $0.28
Guidance: raised
Result: reported results

Exact text from the filing

The Company reported total revenue for the third quarter of 2022 of $783.8 million, a 54% increase as reported, compared to $509.8 million for the third quarter of 2021. This was largely due to the consummation of the business combination that occurred on May 27, 2022 pursuant to a Business Combination Agreement entered into as of December 22, 2021, by and among Quidel Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc (“Ortho”), QuidelOrtho, and the other parties thereto (the “Combinations”). GAAP diluted earnings per share (EPS) for the third quarter of 2022 decreased to $0.28, compared to $5.08 for the third quarter of 2021.

View on SEC.gov

Browse all earnings releases →

QuidelOrtho Corp filing history →

Source: SEC EDGAR

accession 0001906324-22-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.